<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01824147</url>
  </required_header>
  <id_info>
    <org_study_id>33/13</org_study_id>
    <nct_id>NCT01824147</nct_id>
  </id_info>
  <brief_title>ASS-Nonresponse Following Cardiac Surgery as Assessed With Multiple Electrode Aggregometry</brief_title>
  <official_title>ASS-Nonresponse Following Cardiac Surgery as Assessed With Multiple Electrode Aggregometry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Goethe University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Goettingen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Goethe University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is the aim of the present study to assess the prevalence of ASS-Nonresponse following
      cardiac surgery using the Multiple Electrode Aggregometry (MEA).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Up to now there are no data concerning the prevalence of ASS-Nonresponse following surgical
      coronary revascularization procedures as assessed with the Multiple Electrode Aggregometry.
      Results of the present observational study are needed to assess the prevalence of
      ASS-Nonresponse in order to perform a sample size analysis for a prospective interventional
      study in a second step.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Actual">August 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>ASPItest</measure>
    <time_frame>at day 3 and 5 after the first dose of aspirin following surgery</time_frame>
    <description>Area under the aggregation curve following stimulation with arachidonic acid in the Multiple Electrode Aggregometry (MEA)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TRAPtest</measure>
    <time_frame>at day 3 and 5 after the first dose of aspirin following surgery</time_frame>
    <description>Area under the aggregation curve in the Multiple Electrode Aggregometry following stimulation with thrombin receptor activating peptide 6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Platelet Count</measure>
    <time_frame>at day 3 and 5 after the first dose of aspirin following surgery</time_frame>
    <description>Platelet count taken from the daily standard laboratory results.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>12 month</time_frame>
    <description>Mortality will be assessed by a telephonic follow up interview 12 month after enrollment into the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>12 month</time_frame>
    <description>Occurrence of a myocardial infarction during the 12 month following surgery assessed in a telephonic follow up interview.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Readmission to hospital</measure>
    <time_frame>12 month</time_frame>
    <description>Did a readmission to hospital due to cardiac or pulmonary reasons take place in the 12 month following enrollment into the study? Assessed by a telephonic follow up interview.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Age</measure>
    <time_frame>at the day of enrollment</time_frame>
    <description>Age of the patient in years at the time of enrollment</description>
  </other_outcome>
  <other_outcome>
    <measure>Height</measure>
    <time_frame>at the day of enrollment</time_frame>
    <description>Height of the patient in centimeters at the time of enrollment</description>
  </other_outcome>
  <other_outcome>
    <measure>Weight</measure>
    <time_frame>at the day of enrollment</time_frame>
    <description>Weight of the patient in kilograms at enrollment</description>
  </other_outcome>
  <other_outcome>
    <measure>Gender</measure>
    <time_frame>at the day of enrollment</time_frame>
    <description>Gender of the patient</description>
  </other_outcome>
  <other_outcome>
    <measure>LDL cholesterol</measure>
    <time_frame>at the day of enrollment</time_frame>
    <description>LDL cholesterol of the patient in mg/dl at enrollment</description>
  </other_outcome>
  <other_outcome>
    <measure>nicotine</measure>
    <time_frame>at the day of enrollment</time_frame>
    <description>Smoking habits of the patient will be documented at enrollment in the categories:
active smoker
non smoker</description>
  </other_outcome>
  <other_outcome>
    <measure>European system for cardiac operative risk evaluation (EuroSCORE)</measure>
    <time_frame>at the day of enrollment</time_frame>
    <description>EuroSCORE as assessed on admission will be documented.</description>
  </other_outcome>
  <other_outcome>
    <measure>Diabetes</measure>
    <time_frame>at the day of enrollment</time_frame>
    <description>Risk factor diabetes will be documented in the following categories at enrollment:
Diabetes Typ I
Diabetes Typ II without the need for insulin substitution
Diabetes Typ II with the need for insulin substitution</description>
  </other_outcome>
  <other_outcome>
    <measure>Surgical procedure</measure>
    <time_frame>at the day of enrollment</time_frame>
    <description>The surgical procedure performed will be documented.</description>
  </other_outcome>
  <other_outcome>
    <measure>phone number</measure>
    <time_frame>at the day of enrollment</time_frame>
    <description>The phone will be documented for the 12 month follow up interview.</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">400</enrollment>
  <condition>ASS-Nonresponse</condition>
  <arm_group>
    <arm_group_label>CABG Patients</arm_group_label>
    <description>Patients undergoing surgery for coronary revascularization.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients following cardiac surgery and a antiaggregatory therapy with aspirin
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients older than 18 years after cardiac surgery

          -  Antiaggregatory therapy with aspirin postoperatively

        Exclusion Criteria:

          -  known allergy to aspirin

          -  need for an antiaggregatory therapy other than aspirin

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian F Weber, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cooperative Weichteilsarkom Study Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Goethe - University</name>
      <address>
        <city>Frankfurt</city>
        <state>Hessen</state>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Goettingen</name>
      <address>
        <city>Goettingen</city>
        <state>Lower Saxony</state>
        <zip>37073</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Collet JP, Cuisset T, Rangé G, Cayla G, Elhadad S, Pouillot C, Henry P, Motreff P, Carrié D, Boueri Z, Belle L, Van Belle E, Rousseau H, Aubry P, Monségu J, Sabouret P, O'Connor SA, Abtan J, Kerneis M, Saint-Etienne C, Barthélémy O, Beygui F, Silvain J, Vicaut E, Montalescot G; ARCTIC Investigators. Bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med. 2012 Nov 29;367(22):2100-9. doi: 10.1056/NEJMoa1209979. Epub 2012 Nov 4.</citation>
    <PMID>23121439</PMID>
  </reference>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 26, 2013</study_first_submitted>
  <study_first_submitted_qc>March 31, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 4, 2013</study_first_posted>
  <last_update_submitted>February 23, 2016</last_update_submitted>
  <last_update_submitted_qc>February 23, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 24, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Goethe University</investigator_affiliation>
    <investigator_full_name>Christian F. Weber, MD</investigator_full_name>
    <investigator_title>Dr.med. Dr.med. habil Christian F. Weber</investigator_title>
  </responsible_party>
  <keyword>ASS-Nonresponse</keyword>
  <keyword>cardiac</keyword>
  <keyword>surgery</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

